Evidence map›Paper›PMID 28208774›Full record

ArticleMolecules (Basel, Switzerland)2017

Cytotoxicity and Antioxidant Potential of Novel 2-(2-((1H-indol-5yl)methylene)-hydrazinyl)-thiazole Derivatives.

Adriana Grozav, Ioan-Dan Porumb, Luiza Ioana Găină, Lorena Filip, Daniela Hanganu

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. New CuMolecules (Basel, Switzerland) · 2022
    Article
  9. Article
  10. Article
  11. Thiazole Ring-A Biologically Active Scaffold.Molecules (Basel, Switzerland) · 2021
    Review
  12. Article
  13. Article
  14. Article
  15. Screening ofFood technology and biotechnology · 2020
    Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Adriana GrozavDepartment of Organic Chemistry, Faculty of Pharmacy, "Iuliu Haţieganu" University of Medicine and Pharmacy, 8 Victor Babes, Cluj-Napoca RO-400012, Romania. adriana.ignat@umfcluj.ro.
Ioan-Dan PorumbResearch Center on Fundamental and Applied Heterochemistry, Faculty of Chemistry and Chemical Engineering, "Babeş-Bolyai", University, M. Kogalniceanu 1, Cluj-Napoca RO-400028, Romania. pdan@chem.ubbcluj.ro.
Luiza Ioana GăinăResearch Center on Fundamental and Applied Heterochemistry, Faculty of Chemistry and Chemical Engineering, "Babeş-Bolyai", University, M. Kogalniceanu 1, Cluj-Napoca RO-400028, Romania. gluiza@chem.ubbcluj.ro.
Lorena FilipDepartment of Bromatology, Hygiene, Nutrition, Faculty of Pharmacy, "Iuliu Haţieganu" University of Medicine and Pharmacy, 8 Victor Babes, Cluj-Napoca RO-400012, Romania. lfilip@umfcluj.ro.
Daniela HanganuDepartment of Pharmacognosy Faculty of Pharmacy, "Iuliu Haţieganu" University of Medicine and Pharmacy, 8 Victor Babes, Cluj-Napoca RO-400012, Romania. dhanganu@umfcluj.ro.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Newly synthesized 2-(2-((1

Indexed as

Antineoplastic AgentsAntioxidantsCell Line, TumorCell SurvivalFree RadicalsHumansInhibitory Concentration 50Magnetic Resonance SpectroscopyModels, MolecularMolecular ConformationThiazolesAntineoplastic AgentsAntioxidantsFree RadicalsThiazolesantioxidant activitycytotoxic activityDFT calculationindolthiazole

Identifiers

PMID28208774
PMCPMC6155897

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.